Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient (original) (raw)

References

  1. Goodall, E. F., & Morrison, K. E. (2006). Amyotrophic lateral sclerosis (motor neuron disease): Proposed mechanisms and pathways to treatment. Expert Reviews in Molecular Medicine. doi:10.1111/j.1467-9639.2006.00001.x.
  2. Guégan, C., & Przedborski, S. (2003). Programmed cell death in amyotrophic lateral sclerosis. Journal of Clinical Investigation. doi:10.1172/JCI200317610.
  3. Pasinelli, P., & Brown, R. H. (2006). Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nature Reviews. Neuroscience, 7, 710–723. doi:10.1038/nrn1971.
    Article CAS PubMed Google Scholar
  4. Proctor, E. A., Fee, L., Tao, Y., Redler, R. L., Fay, J. M., Zhang, Y., et al. (2015). Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 113(3), 614–619. doi:10.1073/pnas.1516725113.
    Article PubMed PubMed Central Google Scholar
  5. Bensimon, G., Lacomblez, L., & Meininger, V. (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. The New England journal of medicine, 330. doi:10.1056/NEJM199403033300901.
  6. Miller, R. G., Mitchell, J. D., Lyon, M., & Moore, D. H. (2007). Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001447.pub2.
  7. Mitchell, J. D., & Borasio, G. D. (2007). Amyotrophic lateral sclerosis. Lancet, 369, 2031–2041. doi:10.1016/S0140-6736(07)60944-1.
    Article CAS PubMed Google Scholar
  8. Coatti, G. C., Beccari, M. S., Olávio, T. R., Mitne-Neto, M., Okamoto, O. K., & Zatz, M. (2015). Stem cells for amyotrophic lateral sclerosis modeling and therapy: Myth or fact? Cytometry Part A, 87(3), 197–211. doi:10.1002/cyto.a.22630.
    Article CAS Google Scholar
  9. Dellavalle, A., Sampaolesi, M., Tonlorenzi, R., Tagliafico, E., Sacchetti, B., Perani, L., et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nature Cell Biology, 9(3), 255–267. doi:10.1038/ncb1542.
    Article CAS PubMed Google Scholar
  10. Valadares, M. C., Gomes, J. P., Castello, G., Assoni, A., Pellati, M., Bueno, C., et al. (2014). Human adipose tissue derived Pericytes increase life span in Utrn (tm1Ked) Dmd (mdx) /J mice. Stem cell reviews. doi:10.1007/s12015-014-9537-9.
  11. Chen, C.-W., Okada, M., Proto, J. D., Gao, X., Sekiya, N., Beckman, S. A., et al. (2013). Human pericytes for ischemic heart repair. Stem cells (Dayton, Ohio), 31(2), 305–316. doi:10.1002/stem.1285.
    Article CAS Google Scholar
  12. Birbrair, A., Zhang, T., Wang, Z.-M., Messi, M. L., Mintz, A., & Delbono, O. (2014). Pericytes: Multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle. Frontiers in Aging Neuroscience, 6, 245. doi:10.3389/fnagi.2014.00245.
    Article PubMed PubMed Central Google Scholar
  13. Corselli, M., Chen, C.-W., Crisan, M., Lazzari, L., & Péault, B. (2010). Perivascular ancestors of adult multipotent stem cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(6), 1104–1109. doi:10.1161/ATVBAHA.109.191643.
    Article CAS PubMed Google Scholar
  14. Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell, 3(3), 301–313. doi:10.1016/j.stem.2008.07.003.
    Article CAS PubMed Google Scholar
  15. Caplan, A. I., & Sorrell, J. M. (2015). The MSC curtain that stops the immune system. Immunology Letters, 168(2), 136–139. doi:10.1016/j.imlet.2015.06.005.
    Article CAS PubMed Google Scholar
  16. Winkler, E. A, Bell, R. D., & Zlokovic, B. V. (2011). Central nervous system pericytes in health and disease. Nature Neuroscience, 14(11), 1398–1405. doi:10.1038/nn.2946.
  17. Winkler, E. A., Sengillo, J. D., Sagare, A. P., Zhao, Z., Ma, Q., Zuniga, E., et al. (2014). Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proceedings of the National Academy of Sciences of the United States of America, 111(11), E1035–E1042. doi:10.1073/pnas.1401595111.
    Article CAS PubMed PubMed Central Google Scholar
  18. Winkler, E. A., Sengillo, J. D., Sullivan, J. S., Henkel, J. S., Appel, S. H., & Zlokovic, B. V. (2013). Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathologica, 125(1), 111–120. doi:10.1007/s00401-012-1039-8.
    Article CAS PubMed Google Scholar
  19. Assoni, A., Coatti, G., Valadares, M. C., Beccari, M., Gomes, J., Pelatti, M., … Zatz, M. (2016). Different donors mesenchymal stromal cells Secretomes reveal heterogeneous profile of relevance for therapeutic use. Stem Cells and Development, scd.2016.0218. doi:10.1089/scd.2016.0218.
  20. Ray, A., & Dittel, B. N. (2010). Isolation of mouse peritoneal cavity cells. Journal of visualized experiments : JoVE. doi:10.3791/1488.
  21. Gurney, M. E., Pu, H., Chiu, A. Y., Canto, M. C. D., Polchow, C. Y., Alexander, D. D., et al. (1994). Motor neuron degeneration in mice that express a human cu, Zn superoxide dismutase mutation. Science, 264(18), 1–4.
    Google Scholar
  22. Barnéoud, P., Lolivier, J., Sanger, D. J., Scatton, B., & Moser, P. (1997). Quantitative motor assessment in FALS mice: A longitudinal study. Neuroreport, 8(13), 2861–5. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9376520.
  23. Doble, A., & Kennel, P. (2000). Animal models of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 1(5), 301–312. doi:10.1080/146608200300079545.
    Article CAS PubMed Google Scholar
  24. Pfohl, S. R., Halicek, M. T., & Mitchell, C. S. (2015). Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: A meta-analysis. Journal of Neuromuscular Diseases, 2, 137–150. doi:10.3233/JND-140068.
    Article PubMed PubMed Central Google Scholar
  25. Heiman-Patterson, T. D., Deitch, J. S., Blankenhorn, E. P., Erwin, K. L., Perreault, M. J., Alexander, B. K., et al. (2005). Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. Journal of the Neurological Sciences, 236(1–2), 1–7. doi:10.1016/j.jns.2005.02.006.
    Article CAS PubMed Google Scholar
  26. McCombe, P. A., & Henderson, R. D. (2010). Effects of gender in amyotrophic lateral sclerosis. Gender Medicine, 7(6), 557–570. doi:10.1016/j.genm.2010.11.010.
    Article PubMed Google Scholar
  27. Scott, S., Kranz, J. E., Cole, J., Lincecum, J. M., Thompson, K., Kelly, N., et al. (2008). Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 9(1), 4–15. doi:10.1080/17482960701856300.
    Article CAS Google Scholar
  28. Weydt, P., Hong, S. Y., Kliot, M., & Möller, T. (2003). Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport, 14(7), 1051–1054. doi:10.1097/01.wnr.0000073685.00308.89.
    Article PubMed Google Scholar
  29. Liscic, R. M., & Breljak, D. (2011). Molecular basis of amyotrophic lateral sclerosis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(2), 370–372. doi:10.1016/j.pnpbp.2010.07.017.
    Article CAS Google Scholar
  30. Marchetto, M. C. N. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., et al. (2010). A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell, 143(4), 527–539. doi:10.1016/j.cell.2010.10.016.
    Article CAS PubMed PubMed Central Google Scholar
  31. Melo, U. S., Macedo-Souza, L. I., Figueiredo, T., Muotri, A. R., Gleeson, J. G., Coux, G., … Santos, S. (2015). Overexpression of KLC2 due to a homozygous deletion in the non-coding region causes SPOAN syndrome. Human Molecular Genetics, 24(24), ddv388. doi:10.1093/hmg/ddv388.
  32. Mitne-Neto, M., Machado-Costa, M., Marchetto, M. C. N. M., Bengtson, M. H. M., Joazeiro, C. C. A., Tsuda, H., et al. (2011). Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Human Molecular Genetics, 20(18), 3642–3652.
    Article CAS PubMed PubMed Central Google Scholar
  33. Aranda, P. S., LaJoie, D. M., & Jorcyk, C. L. (2013). Bleach gel: A simple agarose gel for analyzing RNA quality. Electrophoresis, 33(2), 366–369. doi:10.1002/elps.201100335.Bleach.
    Article Google Scholar
  34. Pfaffl, M. (2006). Relative quantification. In T. Dorak (Ed.), Real-time PCR (1st ed., pp. 63–82). International University Line.
  35. Collett, D. (2003). Modelling survival data in medical research.
    Google Scholar
  36. Cox, D. R. (1972). Regression models and life tables. Journal of the Royal Statistical Society. Series B (Methodological), 34(2), 187–220.
    Google Scholar
  37. Singer, J. M., & Andrade, D. F. (2000). Analysis of longitudinal data. In P. K. Sen & C. R. Rao (Eds.), Handbook of statistics, volume 18: Bio-environmental and public health statistics (pp. 115–160). Amsterdam: North Holland.
    Google Scholar
  38. Muggeo, V. M. R. (2003). Estimating regression models with unknown break-points. Statistics in Medicine, 22(19), 3055–3071. doi:10.1002/sim.1545.
    Article PubMed Google Scholar
  39. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315–317. doi:10.1080/14653240600855905.
    Article CAS PubMed Google Scholar
  40. Alves, C. J., de Santana, L. P., dos Santos, A. J. D., de Oliveira, G. P., Duobles, T., Scorisa, J. M., et al. (2011). Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Research, 1394, 90–104. doi:10.1016/j.brainres.2011.02.060.
    Article CAS PubMed Google Scholar
  41. Peron, J. P. S., Jazedje, T., Brandão, W. N., Perin, P. M., Maluf, M., Evangelista, L. P., et al. (2012). Human endometrial-derived mesenchymal stem cells suppress inflammation in the central nervous system of EAE mice. Stem Cell Reviews, 8(3), 940–952. doi:10.1007/s12015-011-9338-3.
    Article CAS PubMed Google Scholar
  42. Ohshima, M., Taguchi, A., Tsuda, H., Sato, Y., Yamahara, K., Harada-Shiba, M., et al. (2014). Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia. Brain & Development, 5–7. doi:10.1016/j.braindev.2014.06.010.
  43. James, A. W., Zara, J. N., Zhang, X., Askarinam, A., Goyal, R., Chiang, M., et al. (2012). Perivascular stem cells: A prospectively purified mesenchymal stem cell population for bone tissue engineering. Stem Cells Translational Medicine, 1(6), 510–519. doi:10.5966/sctm.2012-0002.
    Article CAS PubMed PubMed Central Google Scholar
  44. Birbrair, A., Zhang, T., Wang, Z.-M., Messi, M. L., Enikolopov, G. N., Mintz, A., & Delbono, O. (2013). Role of pericytes in skeletal muscle regeneration and fat accumulation. Stem Cells and Development, 22(16), 2298–2314. doi:10.1089/scd.2012.0647.
    Article CAS PubMed PubMed Central Google Scholar
  45. Starling, A., Rocco, P., Passos-Bueno, M. R., Hazan, J., Marie, S. K., & Zatz, M. (2002). Autosomal dominant (AD) pure spastic paraplegia (HSP) linked to locus SPG4 affects almost exclusively males in a large pedigree. Journal of medical genetics. doi:10.1136/jmg.39.12.e77.
  46. Tonini, M. M. O., Pavanello, R. C. M., Gurgel-Giannetti, J., Lemmers, R. J., van der Maarel, S. M., Frants, R. R., & Zatz, M. (2004). Homozygosity for autosomal dominant facioscapulohumeral muscular dystrophy (FSHD) does not result in a more severe phenotype. Journal of Medical Genetics, 41(2), e17 Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1735661&tool=pmcentrez&rendertype=abstract.
    Article CAS PubMed PubMed Central Google Scholar
  47. de Paula, F., Vainzof, M., Passos-Bueno, M. R., de Cássia, M., Pavanello, R., Matioli, S. R., VB Anderson, L., et al. (2002). Clinical variability in calpainopathy: What makes the difference? European journal of human genetics : EJHG, 10(12), 825–832. doi:10.1038/sj.ejhg.5200888.
    Article PubMed Google Scholar
  48. Prockop, D. J., & Youn Oh, J. (2012). Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Molecular Therapy, 20(1), 14–20. doi:10.1038/mt.2011.211.
    Article CAS PubMed Google Scholar
  49. Kota, D. J., DiCarlo, B., Hetz, R. A., Smith, P., Cox, C. S., & Olson, S. D. (2014). Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms. Scientific Reports, 4, 4565. doi:10.1038/srep04565.
    Article PubMed PubMed Central Google Scholar
  50. Waterman, R. S., Henkle, S. L., & Betancourt, A. M. (2012). Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis. PloS One, 7(9), e45590. doi:10.1371/journal.pone.0045590.
    Article CAS PubMed PubMed Central Google Scholar
  51. Waterman, R. S., Tomchuck, S. L., Henkle, S. L., & Betancourt, A. M. (2010). A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PloS One, 5(4), e10088. doi:10.1371/journal.pone.0010088.
    Article PubMed PubMed Central Google Scholar
  52. Kyurkchiev, D., Bochev, I., Ivanova-Todorova, E., Mourdjeva, M., Oreshkova, T., Belemezova, K., & Kyurkchiev, S. (2014). Secretion of immunoregulatory cytokines by mesenchymal stem cells. World journal of stem cells, 6(5), 552–570. doi:10.4252/wjsc.v6.i5.552.
    Article PubMed PubMed Central Google Scholar
  53. Admyre, C., Axelsson, L.-G., von Stein, O., & Zargari, A. (2015). Immunomodulatory oligonucleotides inhibit neutrophil migration by decreasing the surface expression of interleukin-8 and leukotriene B 4 receptors. Immunology, 144(2), 206–217. doi:10.1111/imm.12368.
    Article CAS PubMed PubMed Central Google Scholar
  54. Shibata, N., Nagai, R., Uchida, K., Horiuchi, S., Yamada, S., Hirano, A., et al. (2001). Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Research, 917(1), 97–104. doi:10.1016/S0006-8993(01)02926-2.
    Article CAS PubMed Google Scholar
  55. Shaw, P. J., Ince, P. G., Falkous, G., & Mantle, D. (1995). Oxidative damage to protein in sporadic motor neuron disease spinal cord. Annals of Neurology, 38(4), 691–695. doi:10.1002/ana.410380424.
    Article CAS PubMed Google Scholar
  56. Ferrante, R. J., Browne, S. E., Shinobu, L. A., Bowling, A. C., Baik, M. J., MacGarvey, U., … Beal, M. F. (1997). Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. Journal of neurochemistry.
  57. Robelin, L., & Gonzalez De Aguilar, J. L. (2014). Blood biomarkers for amyotrophic lateral sclerosis: Myth or reality? BioMed Research International, 2014. doi:10.1155/2014/525097.
  58. Patel, B. P., & Hamadeh, M. J. (2009). Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. Clinical nutrition (Edinburgh, Scotland), 28(6), 604–617. doi:10.1016/j.clnu.2009.06.002.
    Article CAS Google Scholar
  59. Reinholz, M. M., Merkle, C. M., & Poduslo, J. F. (1999). Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis. Experimental Neurology, 159(1), 204–216. doi:10.1006/exnr.1999.7142.
    Article CAS PubMed Google Scholar
  60. Williams, J. R., Trias, E., Beilby, P. R., Lopez, N. I., Labut, E. M., Samuel Bradford, C., et al. (2016). Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the copper-chaperone-for-SOD. Neurobiology of Disease. doi:10.1016/j.nbd.2016.01.020.
  61. Egawa, N., Kitaoka, S., Tsukita, K., Naitoh, M., Takahashi, K., Yamamoto, T., et al. (2012). Drug screening for ALS using patient-specific induced pluripotent stem cells. Science Translational Medicine, 4(145). doi:10.1126/scitranslmed.3004052.
  62. Wainger, B. J., Kiskinis, E., Mellin, C., Wiskow, O., Han, S. S. W., Sandoe, J., et al. (2014). Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Reports, 7(1), 1–11. doi:10.1016/j.celrep.2014.03.019.
    Article CAS PubMed PubMed Central Google Scholar
  63. Kemp, K., Mallam, E., Hares, K., Witherick, J., Scolding, N., & Wilkins, A. (2011). Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts. PloS One, 6(10), e26098. doi:10.1371/journal.pone.0026098.
    Article CAS PubMed PubMed Central Google Scholar
  64. Dey, R., Kemp, K., Gray, E., Rice, C., Scolding, N., & Wilkins, A. (2012). Human mesenchymal stem cells increase anti-oxidant Defences in cells derived from patients with Friedreich’s ataxia. The Cerebellum, 861–871. doi:10.1007/s12311-012-0406-2.
  65. Levy, O., Mortensen, L. J., Boquet, G., Tong, Z., Perrault, C., Benhamou, B., … Karp, J. M. (2015). A small-molecule screen for enhanced homing of systemically infused cells. Cell Reports, 1–8. doi:10.1016/j.celrep.2015.01.057.
  66. Zeng, W., Xiao, J., Zheng, G., Xing, F., Tipoe, G. L., & Wang, X. (2015). Antioxidant treatment enhances human mesenchymal stem cell anti-stress ability and therapeutic efficacy in an acute liver failure model. Nature Publishing Group, 1–17. doi:10.1038/srep11100.

Download references